BIO Ventures for Global Health

BVGH - Breaking Barriers to Development



		BIO Ventures for Global Health is harnessing the resources of the biotechnology industry to create new medicines for neglected diseases of the developing world. Our mission is to break down barriers that hinder industry involvement in global health product development and to catalyze new industry investment. Read More...



		BVGH releases report, Closing the Global Health Innovation Gap: A Role for the Biotechnology Industry in Drug Discovery for Neglected Diseases



		BioWorld Covers Sen. Brownback's Voucher Incentive at PGH Forum 2008 BVGH Unveils New Report, Closing the Global Health Innovation Gap BVGH Completes Updated Version of its Global Health Primer BVGH to Co-host Partnering Forum with BIO and the Gates Foundation BVGH/GBC Op-ed on drug-resistant TB Atlanta Journal Constitution, June 1, 2007 » Archives


Congress has created a new incentive for companies to invest in new treatments for neglected tropical diseases. A provision of the Food and Drug Administration Amendments Act (HR 3580) awards a transferable “priority review voucher” to any company that obtains approval for a treatment for a neglected tropical disease. The bill was signed into law on September 27th.

Global Health News

National Post, May 6, 2008
Study Finds 35% of African Antimalarials Substandard

Bangkok Post, May 6, 2008
International Fight Against Dengue Fever Planned

The Globe and Mail, April 30, 2008
New Public Health School for University of Toronto

Washington Times, April 24, 2008
On Eve of World Malaria Day, Sen. Brownback Talks Neglected Diseases

Science News

SciDev.Net, April 28, 2008
Iranian Scientists Develop Diagnostic to Distinguish Leishamaniasis Types

ScienceDaily.com, April 28, 2008
Engineers Create New Technique for Malaria Diagnosis

Laboratorytalk.com, April 28, 2008
Zeiss Microscope Boosts TB Daignosis

Industry News

The Monitor, May 1, 2008
Upstream Records Positive Toxicity Data for Antimalarial Candidate

PharmaLive.com, April 28, 2008
U.S. Adds $192M of Sanofi H5N1 Bulk Vaccine Antigen to Pandemic Stock

Financial Times, April 24, 2008
Acambis Wins Smallpox Vaccine Contract For US Government

AFP, April 23, 2008
Novartis to Cut Malaria Treatment, Coartem, Price by 20%

Genengnews.com, April 17, 2008
Roche and iOWH Partner to Fight Diarrheal Disease

CNNMoney.com, April 17, 2008
Safety Results Good for Upstream Biosciences' Novel HAT Candidates

Joint Press Release, April 9, 2008
Crucell, Aeras, SATVI TB Vaccine Records Positive Phase I Results

» Archives